A study from Hong Kong last week said that even three doses of the Sinovac vaccine did not produce enough antibody response against Omicron and that it had to be boosted by a Pfizer-BioNTech shot to achieve "protective levels.
AstraZeneca has said that it will seek approval for its vaccine from the US FDA in the.
But, on the other hand, a United Kingdom study published in the New England Journal of Medicine found that the Pfizer-BioNTech vaccine was 88 per cent effective against the Delta variant.
Among the Norwegian fatalities were 13 residents of nursing homes and some 85-year-olds.
The truth is — is not a good COVID-19 vaccine, which is why the National COVID-19 Immunisation Program PICK no longer offers it.
.